Antithrombin Acts as a Negative Acute Phase Protein as Established with Studies on HepG2 Cells and in Baboons

Summary

Patients with sepsis or after major surgery have decreased plasma levels of the anticoagulant protein antithrombin. In such patients elevated levels of interleukin-6 (IL-6) are present and this interleukin is known to induce positive and negative acute phase responses. To investigate the possibility that antithrombin acts as a negative acute phase response-protein we performed studies on the human hepatoma cell line HepG2 in vitro and baboons in vivo. HepG2 cells were treated with recombinant human IL-6, ILß3, or combinations of the latter two, and tested for production of antithrombin, fibrinogen and prealbumin (transthyretin). This treatment resulted in a dose dependent increase in fibrinogen concentration (with a maximum effect of 2.8-2.9-fold) and a dose dependent decrease in prealbumin (with a maximum effect of 0.6-0.7-fold) and antithrombin concentrations (with a maximum effect of 0.6-0.8-fold). Simultaneous treatment of the HepG2 cells with IL-6 (1,000 pg/ml or 2,500 pg/ml) and IL-1β (25 pg/ml), provided more extensively decreased prealbumin (0.8 and 0.6-fold, respectively) and antithrombin concentration (0.7 and 0.6-fold, respectively) compared to the single interleukin treatment at these concentrations. Baboons treated with 2 µg IL-6 · kg body-weight^-1 · day¹ showed increased plasma CRP levels (59-fold, p <0.05) and decreased prealbumin (0.9-fold, p <0.05) and antithrombin (0.8-fold, p <0.05) plasma levels, without evidence for coagulation activation. Our results indicate that antithrombin acts as a negative acute phase protein, which may contribute to the decreased antithrombin plasma levels observed after major surgery or in sepsis.

• References

• 1 Scientific and Standardization Committee Communications. Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). Thromb Haemost 1994; 71: 375-394
• 2 Rosenberg RD, Damus PS. The purification and mechanism of antithrom bin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
• 3 Buchanan MR, Boneu B, Ofosu F, Hirsch J. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Blood 1985; 65: 198-201
• 4 Schipper HG, Roos J, van de Meulen, ten Cate JW. Antithrombin III de ficiency in surgical intensive care patients. Thromb Res 1981; 21: 73-80
• 5 Biiller HR, Bolwerk C, ten Cate J, Roos J, Kahlé HL, ten Cate JW. Post operative hemostatic profile in relation to gram-negative septicemia. Crit CareMed 1982; 10: 311-315
• 6 Brandtzaeg P, Sandset PM, Joo GB, Ovstebo R, Abildgaard U, Kierulf P. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococ cal disease. Thromb Res 1989; 55: 459-470
• 7 Koj A. Definition and classification of acute-phase proteins. in: The acute phase response to injury and infection. Gordon AH, Koj A. (eds). Amster dam: Elsevier; 1985. pp 139-232
• 8 Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984; 2: 283-318
• 9 Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, interleukin 1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 1986; 103: 787-93
• 10 Perlmutter DH, Dinarello CA, Punsai PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986; 78: 1349-54
• 11 Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. New Engl J Med 1984; 311: 1413-8
• 12 Hack CE, de GrootER, Felt-Bersma RJF, Nuijens JH, Strack vanSchijndel, Eerenberg BelmerA, Thijs LG, Aarden LA. Increased plasma lev els of interleukin-6 in sepsis. Blood 1989; 74: 1704-1710
• 13 Wortel CH, van DeventerJH, Aarden LA, Lygidakis NJ, Biiller HR, Hoek JF, Horikx J, ten Cate JW. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 1993; 114: 564-570
• 14 Gauldie J, Richards C, Hamish D, Lansdorp P, Baumann H. Interferon β₂/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84: 7251-7255
• 15 Castell JV, Gomez LechonM, David M, Andus T, Geiger T, Trullenque R, Farba R, Heinrich PC. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237-239
• 16 Morrone G, Ciliberto G, Oliviero S, Arcone R, Dente L, Content J, Cortese R. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem 1988; 263: 12554-12558
• 17 Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the syn thesis of a specific set of acute phase plasma proteins in vivo. J Immunol 1989; 142: 808-812
• 18 Yap SH, Moshage HJ, Hazenberg BPC, Roelofs HMJ, Bijzet J, Limburg PC, Aarden LA, van RijswijkMH. Tumor necrosis factor (TNF) inhibits interleukin (IL)-l and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepato cytes. Biochim Biophys Acta 1991; 1091: 405-408
• 19 Dofferhoff ASM, de Jong HJ, Bom VJJ, van der MeerJ, Limburg PC, de Vries-Hospers HG, Marrink J, Mulder POM, Weits J. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 1992; 24: 197-204
• 20 Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 491-499
• 21 Niessen RWLM, Pfaffendorf BA, Sturk A, Lamping RJ, Schaap MCL, Hack CE, Peters M. The influence of insulin, B-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells. Thromb Haemost 1995; 74: 686-692
• 22 Baumann H, Richards C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 1987; 139: 4122-4128
• 23 Bartalena L, Farsetti A, Flink IL, Robbins J. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (HepG2) cells. Mol Endocrinol 1992; 06: 935-942
• 24 De BoerJP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, Lambers JWJ, vffi MourikJA, Hack CE. PAI-I synthesis in the human hepatoma cell line HepG2 is increased by cytokines Evidence that the liver contributes to acute phase behaviour of PAI-I. Thromb Haemost 1991; 65: 181-185
• 25 Le J, Vilcek J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588-602
• 26 Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636
• 27 Stathakis N, Papayannis AG, Gardikas CD. Postoperative antithrombin III concentration. Lancet 1973; 01: 430
• 28 Aberg M, Nilsson IM, Hedner U. Antithrombin III after operation. Lancet 1973; 02: 1337 (letter).